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Abstract
Background: The Cajal body (CB) is a nuclear suborganelle involved in the biogenesis of small
nuclear ribonucleoproteins (snRNPs), which are vital for pre-mRNA splicing. Newly imported Sm-
class snRNPs traffic through CBs, where the snRNA component of the snRNP is modified, and then
target to other nuclear domains such as speckles and perichromatin fibrils. It is not known how
nascent snRNPs localize to the CB and are released from this structure after modification. The
marker protein for CBs, coilin, may play a role in snRNP biogenesis given that it can interact with
snRNPs and SMN, the protein mutated in Spinal Muscular Atrophy. Loss of coilin function in mice
leads to significant viability and fertility problems and altered CB formation.
Results: In this report, we identify a minor isoform of the mitochondrial Tim50, Tim50a, as a coilin
interacting protein. The Tim50a transcript can be detected in some cancer cell lines and normal
brain tissue. The Tim50a protein differs only from Tim50 in that it contains an additional 103 aa N-
terminal to the translation start of Tim50. Importantly, a putative nuclear localization signal is found
within these 103 residues. In contrast to Tim50, which localizes to the cytoplasm and mitochondria,
Tim50a is strictly nuclear and is enriched in speckles with snRNPs. In addition to coilin, Tim50a
interacts with snRNPs and SMN. Competition binding experiments demonstrate that coilin
competes with Sm proteins of snRNPs and SMN for binding sites on Tim50a.
Conclusion: Tim50a may play a role in snRNP biogenesis given its cellular localization and protein
interaction characteristics. We hypothesize that Tim50a takes part in the release of snRNPs and
SMN from the CB.
Background
The biogenesis of most spliceosomal small nuclear ribo-
nucleoproteins (snRNPs) is complicated and requires
both cytoplasmic and nuclear maturation steps [1-3]. For
example, the spliceosomal small nuclear RNAs (snRNAs)
of Ul, U2, U4 and U5 snRNPs are synthesized by RNA
polymerase II and may traffic through specific subnuclear
domains before being exported to the cytoplasm [1,3]. In
the cytoplasm, a septet of Sm proteins (B/B', Dl, D2, D3,
E, F, G) binds the Sm motif of the snRNA under the con-
trol of the Survival of Motor Neurons (SMN) protein com-
plex. Mutations in the SMN protein cause the
neurodegenerative disorder Spinal Muscular Atrophy
[4,5]. After the Sm core has been assembled onto the
snRNA, the snRNA is subject to further processing,
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followed by import back into the nucleus; again with the
help of the SMN complex [1,5-8].
Upon nuclear re-entry, newly assembled Ul, U2, U4 and
U5 snRNPs first localize to a subnuclear domain known as
the Cajal body [9]. In the Cajal body (CB), the snRNA
component of the snRNP is subjected to pseudouridine-
base and 2'-0-methyl sugar-modifications that are guided
by small CB-specific RNAs (scaRNAs) [10-12]. These
modifications are crucial for proper pre-mRNA splicing in
vivo [13]. After their modification in the CB, snRNPs
localize to speckles, where they are stored, or perichroma-
tin fibrils, where splicing occurs concurrently with tran-
scription [14]. Unlike Ul, U2, U4 and U5 snRNAs,
maturation of the RNA polymerase III-transcribed U6
snRNA does not include a cytoplasmic phase and may
take place in the nucleolus and the CB [3]. The U7 snRNP,
which is required for histone pre-mRNA 3'-end processing
[15-17], is assembled in manner similar to that observed
for Ul, U2, U4 and U5 snRNPs, including a cytoplasmic
phase [18]. However, U7 snRNA has a noncanonical Sm
binding site and thus recruits a different type of Sm core
compared to that which binds Ul, U2, U4 and U5 snRNA
[19,20]. Like the spliceosomal snRNPs, the U7 snRNP is
enriched within CBs [19,21]. CBs have been shown to
move in an ATP dependent manner [22,23] as well as
associate with various gene loci, including snRNA and his-
tone gene clusters [24]. Consequently, CBs may provide a
platform upon which a feedback regulatory mechanism
for snRNP and histone biogenesis takes place [25].
The mechanisms by which snRNPs are targeted to and
released from the CB are unknown. One possibility is that
a factor within the CB interacts with nascent snRNPs and
facilitates their modification. Another factor may displace
snRNPs from the CB, allowing for their subsequent local-
ization in speckles and perichromatin fibrils. The CB
marker protein coilin may play a role in the targeting of
snRNPs to CBs. Removal of coilin in Xenopus by immun-
odepletion decreases snRNP levels in the amphibian
equivalent of the CB [26]. Characterization of coilin
knockout mice has revealed that they are viable on an out-
bred mouse strain, but have significant viability and fertil-
ity defects on inbred strains [27] (Greg Matera, personal
communication). Cell lines derived from coilin knockout
mice lack canonical CBs in which snRNPs are enriched
[27]. However, add-back experiments demonstrate that
typical CBs, containing snRNPs, can be reformed upon
the addition of coilin [27]. Furthermore, coilin can inter-
act directly with several Sm proteins of snRNPs [28] (our
unpublished observations). Taken together, these data
indicate that, while not an essential protein, coilin is
important for proper CB formation. Functional CBs may
allow for the efficient coordination of the nuclear steps of
snRNP biogenesis.
Another protein that requires coilin for its localization to
CBs is SMN [27-30]. Coilin directly interacts with SMN via
several arginine/glycine (RG) dipeptide repeats in coilin
[28]. The arginines within this RG box motif are symmet-
rically dimethylated [29,30], resulting in an increased
affinity for SMN [31,32]. In most cell lines and tissues,
SMN localizes to the cytoplasm and CBs [33]. However,
SMN in some cell lines and fetal tissue localizes to discrete
nuclear structures termed "gems" (for Gemini of Cajal
bodies) [34,35]. The presence of gems correlates with a
decrease in coilin methylation [29,30]. Although the
nuclear role of SMN is not well understood, it is possible
that SMN escorts nascent snRNPs to the CB [6,8]. Interest-
ingly, coilin can compete with Sm proteins for binding
sites on SMN [28], indicating that locally high concentra-
tions of coilin within the CB may serve to displace snRNPs
from the SMN complex. The interplay between SMN,
snRNPs and coilin may therefore regulate snRNP accumu-
lation within the CB. We set out to determine if we could
identify factors that control the departure of nascent
snRNPs from the CB.
In this report, we demonstrate that an isoform of the
human mitochondrial Tim50, Tim50a, localizes to speck-
les and interacts with snRNPs, SMN and coilin. Human
Tim50, which has phosphatase activity, is a component of
the mitochondrial translocator and regulates mitochon-
drial integrity and cell death [36]. The protein sequence of
Tim50 and Tim50a are identical, with the important
exception that Tim50a contains an alternative transla-
tional start sequence that adds 103 aa to its N-terminus
relative to Tim50. Competition binding experiments
show that SmB' does not compete with SMN for Tim50a
binding sites, but SmB' does reduce coilin interaction with
Tim50a. Furthermore, SMN and coilin compete for
Tim50a binding sites and Tim50a forms a more efficient
complex with snRNPs in vivo compared to Tim50. Based
on these results, we propose that Tim50a is involved in
the regulation of snRNP biogenesis and possibly the activ-
ity of nuclear SMN.
Results and discussion
Isolation of Tim50a
Given the central role of coilin in the formation and com-
position of CBs, especially in its ability to recruit the SMN
complex and snRNPs, we wanted to identify proteins that
interact with coilin and possibly regulate SMN and snRNP
localization in the CB. Towards this end, we conducted a
yeast two-hybrid screen with coilin as bait. A human brain
cDNA library was chosen for this screen because we are
interested in assessing CB protein dynamics in neuronal
tissue, which is the cell type primarily affected in Spinal
Muscular Atrophy. The C-terminal 214 aa of coilin, which
interacts with SMN and Sm proteins, was the bait for the
screen [28] (our unpublished observations).BMC Cell Biology 2005, 6:29 http://www.biomedcentral.com/1471-2121/6/29
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Consequently, other proteins that bind C214 may regu-
late the interplay between coilin/SMN and coilin/Sm and
thus play a role in CB dynamics.
Several preys were recovered from the screen, one of
which was termed CAP50. Sequencing of this prey
revealed that it contained the partial coding sequence for
a protein known as Tim50. Since Tim50 localizes to the
mitochondria and cytoplasm [36], the relevance of CAP50
interaction with coilin, a nuclear protein, was not initially
clear. However, upon conducting EST (expressed
sequence tag) database searches, we found that there are
two possible translational starts for the TIMM50  gene
product. The majority of ESTs terminate slightly upstream
of the published translational start sequence of Tim50
(MAASA, [36]), suggesting that Tim50 is the major prod-
uct of the TIMM50 gene. However, three ESTs, all from
cancer cells lines, demonstrate that an alternative transla-
tional start sequence can be utilized which would add 103
aa to the N-terminus of the Tim50 protein. We have
named this protein Tim50a (Figure 1A). Importantly, a
putative nuclear localization signal (NLS) [37] is found
within this region, indicating that Tim50a, unlike Tim50,
may reside in the nucleus.
To verify the existence of Tim50a in other cell lines and to
obtain a general idea as to the abundance of this transcript
relative to the Tim50 isoform, we performed nested PCR
with primers specific to Tim50a on cDNAs from four
additional cancer cell lines: A-549, NIH: OVCAR-3, MDA-
MB-231 and HCT-15. Another primer set was used in a
standard (not nested) PCR reaction to amplify a region
common to both Tim50a and Tim50 (Figure 1B). As
shown in Figure 1C (upper panel), a standard PCR reac-
N-terminal amino acid alignment and relative expression of Tim50a and Tim50 Figure 1
N-terminal amino acid alignment and relative expression of Tim50a and Tim50. (A) Compared to Tim50, Tim50a 
contains additional sequence that contains a putative nuclear localization sequence (NLS) upstream of the translational start of 
Tim50. (B) Schematic representation (not to scale) of Tim50a and Tim50 showing the locations of the primers used in the PCR 
reactions. (C) The relative expression of Tim50 versus Tim50a in four cancer cell lines. (Upper panel) A standard PCR reaction 
using cDNA from each cell line as template and ComFor+ComRev primers yields a product that could be from Tim50 and 
Tim50a. Water serves as a negative control while Tim50a plasmid cDNA serves as a positive control. Nested PCR (lower 
panel) demonstrates that Tim50a is detected in two cell lines but accounts for only a small fraction of the products from the 
TIMM50 gene. The cDNA from the following cell lines was used: A-549 (non-small cell lung cancer), NIH: OVCAR-3 (ovarian 
cancer), MDA-MB-231 (breast cancer) and HCT-15 (colon cancer). The lower band in the NIH: OVCAR-3 nested PCR reac-
tion is a non-specific product.
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tion (30 cycles) using primers that can bind both Tim50a
and Tim50 (ComFor+ComRev) generate a product from
all of the cell lines tested. In contrast, standard PCR reac-
tions using Tim50a-specific primers (50aFor+50aRev) fail
to yield a product from cell line cDNAs, but successfully
generate a product using a positive control plasmid tem-
plate (our unpublished observations). However, nested
PCR (20 cycles) reveals that two of the four cell lines, A-
549 and NIH: OVCAR-3, contain the Tim50a transcript
(Figure 1C, lower panel), as monitored by sequencing of
the product. The lower band in the NIH: OVCAR-3 reac-
tion is from an unrelated transcript. Therefore, while
Tim50a mRNA is not nearly as abundant as the Tim50
message, this species is present in at least four different
cell lines (two lines from this study and two from the EST
database).
Cellular localization of Tim50a
To test if Tim50a is a nuclear protein, we obtained an EST
encoding the additional residues and cloned the entire
Tim50a coding sequence into a GFP expression vector. We
also made a GFP fusion to the truncated Tim50 protein
isolated from the two-hybrid screen (CAP50) as well as
GFP fusions to various mutants of Tim50a. The localiza-
tion of these proteins, and GFP fused to the mitochon-
drial Tim50 isoform, was monitored after transient
transfection into HeLa cells (Figures 2 and 3). In contrast
to Tim50, GFP-Tim50a is exclusively nuclear with speckle-
like accumulations (Figure 3). To confirm that the nuclear
accumulations are indeed speckles, in which snRNPs are
stored, we stained the cells with antibodies against Sm
proteins (Y12). There is overlap between Tim50a and
snRNPs in speckles (arrows), as shown by the yellow-
orange signal in the merged image (Figure 4, row 1, right
panel). We do not detect Tim50a in Cajal bodies (arrow-
heads), indicating that the association of Tim50a with
CBs or coilin is weak or transient. Alternatively, coilin may
associate with Tim50a in the nucleoplasm. Indeed, while
coilin is highly enriched in the CB, the majority (70%) of
the protein is diffusely localized throughout the nucleo-
plasm [38]. We observed identical localization patterns
for Tim50a upon fusion to a smaller myc-tag (our unpub-
lished results), suggesting that the GFP-tag does not affect
localization. The diffuse cytoplasmic and nuclear localiza-
tion of GFP-CAP50 and GFP-Tim50a(N87) demonstrate
that the region containing the putative NLS is necessary
for nuclear localization (Figure 4). Tim50a mutants that
retain the putative NLS display nuclear accumulation. For
example, an internal deletion of Tim50a (Tim50aSac) is
found in a speckled nuclear pattern while the first 135 aa
(Tim50aN135) is nuclear and nucleolar. Tim50a localiza-
tion to speckles is therefore contingent upon the NLS and
residues found between aa 135 and 256.
Schematic representation and cellular localization of Tim50a constructs used in this study Figure 2
Schematic representation and cellular localization of Tim50a constructs used in this study. The Tim50a protein is 
456 aa in length. Note that Tim50, reported by [36], lacks an NLS, which is present in Tim50a, Tim50aSac and Tim50aN135. 
Tim50aSac contains a deletion between aa 256 and 431.
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Actinomycin D redistribution of Tim50a
The transcription inhibitor actinomycin D can be used to
partially characterize the interaction of proteins in the
nucleus. This is because actinomycin D inhibits transcrip-
tion and causes the reorganization of splicing factors and
Cajal bodies [39]. In particular, speckles enlarge and CBs
are relocalized to the periphery of the nucleolus in the
presence of actinomycin D [39]. If Tim50a were an inte-
gral part of speckles, then we would suspect that this pro-
tein would be found in enlarged speckles when cells are
treated with actinomycin D. However, in the presence of
actinomycin D, Tim50a no longer localizes with snRNPs
in speckles but is instead found in discrete structures (Fig-
ure 5, bottom panels, arrows). This is evident in the
merged image, which shows separate green (GFP-Tim50a,
arrows) and red (snRNPs, arrowheads) signals with little
overlap. In contrast, non-treated cells display overlap
between Tim50a and snRNPs, resulting in a yellow-
orange signal in the merged image (Figure 5, top panels).
We tested whether Tim50a in actinomycin D treated cells
localized to paraspeckles, another subnuclear domain of
unknown function [40]. No colocalization of Tim50a
with the paraspeckle marker protein, PSP1, was observed
(data not shown). Taken together, the localization data
indicate that Tim50a is likely to have a different function
compared to Tim50, possibly in the regulation of CB
activity or snRNP biogenesis. However Tim50a is not an
integral component of speckles given the separate locali-
zation pattern of Tim50a and snRNPs in actinomycin D
treated cells.
Direct interaction of Tim50a with coilin, SmB' and SMN
The two-hybrid screen suggests that Tim50 isoforms may
interact with coilin. To prove this, we conducted GST-
pulldown assays using bacterially purified T7-tagged coi-
lin and Tim50a fused to GST. Coilin is not recovered over
Cellular localization of GFP-tagged Tim50a and Tim50 Figure 3
Cellular localization of GFP-tagged Tim50a and Tim50. HeLa cells were transfected with GFP-Tim50a (top row) or 
GFP-Tim50 (bottom row) and the cells were stained with DAPI to define the nucleus. The right panels show the overlay of the 
GFP signal (green) with the DAPI signal (blue). Note that GFP-Tim50 has extensive cytoplasmic staining but Tim50a is exclu-
sively nuclear. The nuclear signal for GFP-Tim50 was not reported by [36] and may be caused by overexpression and/or fusion 
of GFP to the N-terminus of the protein.
Tim50a
Tim50
GFP DAPI MergeBMC Cell Biology 2005, 6:29 http://www.biomedcentral.com/1471-2121/6/29
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Cellular localization of various Tim50a proteins Figure 4
Cellular localization of various Tim50a proteins. Hela cells were transfected with GFP-tagged proteins (first column), 
followed by staining with antibody Y12 (second column) to detect Sm proteins (snRNPs). The merged image in color is shown 
in the last column (GFP is green, Sm proteins are red). Arrows mark speckles whereas arrowheads demarcate Cajal bodies. 
Note that cells for GFP-CAP50 and GFP-Tim50aN87 are shown at a lower magnification compared to the other images in 
order to demonstrate the cytoplasmic localization of these proteins.BMC Cell Biology 2005, 6:29 http://www.biomedcentral.com/1471-2121/6/29
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beads fused to GST alone, but is recovered over GST-
Tim50a beads (Figure 6A). We next tested if Tim50a
would interact with the C-terminal 214 aa of coilin
(C214), which is this same fragment of coilin used to iso-
late CAP50 in the two-hybrid screen. In agreement with
the two-hybrid results, soluble Tim50a is recovered over
GST-C214 beads, but not by GST alone (Figure 6B). Since
Tim50a localizes to speckles, we were interested in assess-
ing if Tim50a interacts with Sm proteins of snRNPs. Using
SmB' as a representative of Sm proteins, we conducted
GST-pulldown experiments with a variety of GST-Tim50a
proteins. Consistent with the localization data, SmB'
directly interacts with GST-Tim50a (Figure 6C, lane 4).
SmB' also associates with two mutants of Tim50a, CAP50
and Tim50Sac. Based on the binding results, we suspect
that the interaction domain for SmB' on Tim50a lies
somewhere between residues 121 and 256 of Tim50a,
although we cannot exclude the role of the residues at the
extreme C-terminus of Tim50a (aa 431–456, Figure 2).
Given that Tim50a localizes to speckles and directly inter-
acts with coilin and SmB', we next tested if Tim50a could
interact with another protein crucial for snRNP forma-
tion, SMN. As shown in Figure 6D, SMN binds to the GST-
Tim50a proteins but not to GST alone. We also examined
if the isoform known to localize in mitochondria, Tim50,
also interacts with the coilin fragment C214 as found for
Tim50a. Purified full-length Tim50 does indeed interact
specifically with the coilin fragment as shown in Figure
6E. From these in vitro binding studies, we conclude that
coilin, SmB' and SMN can interact with both Tim50a and
Tim50 isoforms, but the interaction of these proteins in
vivo is likely regulated by their subcellular localization.
Actinomycin D treatment alters the co-localization of Tim50a with snRNPs Figure 5
Actinomycin D treatment alters the co-localization of Tim50a with snRNPs. HeLa cells transfected with GFP-tagged 
Tim50a (green) were untreated or subject to actinomycin D, followed by fixation and staining with the anti-Sm antibody Y12 
(red). The overlay of the images is shown in the last column. For untreated cells, arrowheads mark the location of Cajal bodies 
and arrows show speckles. For actinomycin D treated cells, arrows mark accumulations of Tim50a while arrowheads show 
enlarged Sm speckles.BMC Cell Biology 2005, 6:29 http://www.biomedcentral.com/1471-2121/6/29
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SmB' and SMN compete with coilin for Tim50a binding 
sites
The ability of Tim50a to bind coilin, SmB' and SMN raises
the interesting possibility that this protein may regulate
the dynamics of CB proteins. To test this hypothesis, we
conducted competition GST-pulldown experiments using
GST-Tim50aSac. This protein was used instead of GST-
Tim50a (Figure 2) because it is more easily purified com-
pared to GST-Tim50a and has similar binding capabilities
(Figure 6C and 6D). For the first experiment, we tested if
SMN and SmB' vie for the same binding sites on Tim50a.
This was accomplished by incubating a fixed amount of
Tim50a directly interacts with coilin, SMN and SmB' Figure 6
Tim50a directly interacts with coilin, SMN and SmB'. GST-pulldown assays were conducted on bacterially purified pro-
teins. (A) Tim50a interacts with coilin. Soluble coilin was incubated with beads loaded with GST or GST fused to Tim50a. After 
incubation and washes, the reactions were subject to Western blotting and probing with antibodies to coilin. The input lane 
accounts for 26% of the coilin used in the pulldown reactions. The bottom panel is a coomassie stained gel demonstrating the 
levels of GST-Tim50a (lane 2) and GST (lane 3) used in the pulldown assay. (B) Tim50a interacts with the C-terminus of coilin. 
Soluble TV-tagged Tim50a was incubated with beads loaded with GST or GST fused to the C-terminal 214 aa of coilin (C214, 
the same portion of coilin used in the two-hybrid screen). After incubation and washes, the proteins were subject to Western 
blotting and probing with antibodies to T7. The input lane accounts for 20% of the Tim50a used in the pulldown reactions. (C) 
SmB' interacts with Tim50a and mutants thereof. T7-tagged SmB' was incubated with GST, GST-CAP50, GST-Tim50a or GST-
Tim50aSac, followed by washing and probing with anti-T7 antibodies. The input lane accounts for 20% of the SmB' used in the 
pulldown reactions. (D) SMN interacts with GST-CAP50, GST-Tim50a and GST-Tim50aSac. Soluble T7-SMN was incubated 
with various GST fusions, followed by Western blotting and probing with anti-T7 antibodies. The input lane accounts for 10% 
of the SMN used in the reactions. (E) The mitochondrial Tim50 protein interacts with the C-terminus of coilin in vitro. Soluble 
T7-tagged Tim50 was incubated with GST or GST-C214 beads, followed by Western blotting and probing with antibodies to 
T7. The input lane (lane 1) accounts for 20% of the Tim50 used in the pulldown reactions. The membrane was stained with 
Ponceau S to verify that equivalent amounts of GST proteins were used in the assay.
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GST-Tim50aSac with a constant amount of SMN and, in
separate reactions, an increasing amount of SmB'. Despite
binding a large amount of SmB' (Figure 7A, top panel),
the level of SMN recovered by the GST-Tim50aSac beads
does not change (Figure 7A, bottom panel, compare the
SMN level in lane 6 to that in lane 2). We conclude that
Tim50a has separate binding sites for SMN and SmB' and
that one protein does not preclude the other from
binding.
We then tested if coilin and SmB' compete for binding
sites on Tim50a. For this experiment, we incubated a fixed
amount of GST-Tim50aSac with a constant amount of a
coilin fragment (C214) and, in separate reactions, an
increasing amount of SmB'. As shown in Figure 7B,
increasing the level of SmB' decreases the recovery of the
coilin fragment (C214) by GST-Tim50aSac (bottom
panel, compare the amount of C214 recovered in lane 4
to that in lane 2). Thus coilin and SmB' compete for bind-
ing sites on Tim50a.
Finally we monitored if coilin and SMN compete for the
same binding sites on Tim50a. This experiment was
conducted with a fixed amount of GST-Tim50aSac and a
constant amount of SMN with increasing levels of the coi-
lin fragment (C214). The binding of the respective pro-
teins to the Tim50a substrate in the absence of competitor
(Figure 7C) is shown in lane 2 (upper panel) for the coilin
fragment and lane 3 (lower panel) for SMN. In reactions
with both soluble proteins, as the level of coilin fragment
(C214) is increased, the amount of SMN recovered by the
Tim50a beads is reduced (compare the SMN signal in lane
7 to that in lane 3). These data are consistent with a com-
petition for Tim50a binding sites by SMN and coilin.
Given its protein interaction potential, we hypothesize
that Tim50a may affect CB function by interacting with
proteins that localize to this domain. One possible sce-
nario is that Tim50a displaces snRNPs from the CB and
facilitates their translocation to speckles. Tim50a may also
disrupt the interaction between coilin and SMN, allowing
for SMN to leave the CB.
Tim50a interacts with SMN and snRNPs in vivo
To corroborate the direct interaction data, we tested if
Tim50a could associate with SMN in cells. For these exper-
iments, we transfected HeLa cells with empty GFP vector,
GFP-tagged full-length Tim50a or GFP fused to the N-ter-
minal 87 aa of Tim50a. After incubation, lysates were
made and subjected to immunoprecipitation with anti-
GFP antibodies, followed by western blotting with anti-
SMN antibodies. As shown in Figure 8A (upper panel), no
SMN is co-immunoprecipitated with GFP alone but SMN
is recovered by GFP-Tim50a. Only a faint SMN signal is
observed in the GFP-Tim50a(N87) reaction (lane 3), sug-
gesting that this fragment does not contribute signifi-
cantly to the ability of SMN to bind Tim50a. Reprobing of
this same blot with anti-GFP (bottom panel) demon-
strates that while a large amount of GFP and GFP-
Tim50a(N87) were immunoprecipitated, little SMN was
recovered. In contrast, the amount of
immunoprecipitated GFP-Tim50a is less than that
obtained for GFP and GFP-Tim50a(N87), yet more SMN
was recovered. Thus Tim50a can form a complex with
SMN in cells.
Given that Tim50a localizes to speckles, in which snRNPs
are stored, and directly interacts with a subunit of the Sm
core, it is likely that Tim50a will interact with intact
snRNPs. However, the in vitro binding data indicate that
the mitochondrial isoform, Tim50, also has the potential
to interact with snRNPs, which are known to have a cyto-
plasmic phase. To test this, we conducted a co-immuno-
precipitation assay on HeLa cells transfected with empty
GFP vector or GFP fused to Tim50a or Tim50. Lysates were
generated and subject to incubation with the anti-Sm anti-
body Y12. After SDS-PAGE and Western transfer, the blot
was probed with anti-GFP antibodies to monitor the asso-
ciation of GFP-Tim50a or GFP-Tim50 with snRNPs. As
shown in Figure 8B, a signal corresponding to GFP-
Tim50a is present in the Y12 immunoprecipitation reac-
tion (lane 5). In contrast, less Tim50 is co-immunoprecip-
itated by Y12 (lane 6) compared to Tim50a. A GFP-alone
signal is not observed in the Y12 reaction (lane 4), dem-
onstrating the specificity of the reaction. Therefore, in
vivo, Tim50a appears to be more efficient in snRNP inter-
action than Tim50, although we have not excluded the
possibility that the GFP-tag may adversely affect Tim50
interactions. To address this point, Tim50a and Tim50
proteins were fused to smaller myc-tags, expressed in
HeLa cells and tested for interaction with an immobilized
Sm protein, SmB'. Both proteins bind GST-SmB', indicat-
ing that the GFP-tag may indeed contribute to the reduced
interaction of Tim50 with snRNPs (Figure 8C). Alterna-
tively, the faint Tim50 signal observed in the Y12 co-
immunoprecipitation reaction (lane 6) may be an artifact
due to the overexpression of GFP-Tim50 and subsequent
nuclear localization, as shown in Figure 3. In support of
this thought, immunofluorescence analysis of
endogenous Tim50 demonstrates that this protein is pre-
dominantly cytoplasmic with little nuclear accumulation
[36]. Given that Tim50a is a nuclear protein, we speculate
that Tim50a interactions may regulate the nuclear activity
of SMN and trafficking of snRNPs, possibly by altering the
dynamics of the association between SMN, coilin and
snRNPs. Additionally, it is plausible that cytoplasmic
SMN can interact with Tim50 before mitochondrial
import.BMC Cell Biology 2005, 6:29 http://www.biomedcentral.com/1471-2121/6/29
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SmB' and SMN compete with coilin for Tim50a binding sites Figure 7
SmB' and SMN compete with coilin for Tim50a binding sites. Competition GST-pulldown experiments are shown. (A) 
SMN does not compete with SmB' for Tim50a binding sites. GST-Tim50aSac was incubated in separate reactions with SmB' 
(lane 2, top) or SMN (lane 2 bottom) followed by probing with anti-T7 (to detect SmB') and anti-SMN (to detect SMN). Lanes 
3–6 show separate reactions in which a fixed amount of SMN was incubated with GST-Tim50aSac along with an increasing 
amount of SmB'. In lane 6, 27 times more SmB' was used in the reaction compared to the level of SMN. The input lanes 
account for 20% of the amounts used in all the reactions for SMN and the reactions shown in lane 2 and 3 for SmB'. (B) SmB' 
competes with coilin for Tim50a binding sites. GST-Tim50aSac was incubated with a fixed amount of the C-terminal coilin frag-
ment (C214) and an increasing amount, in separate reactions, of SmB'. After Western blotting, anti-T7 was used to detect SmB' 
(top) and anti-coilin was used to detect C214 (bottom). Lane 4 shows the result of a reaction in which 3 times more SmB' 
compared to C214 was used in the binding assay with GST-Tim50aSac. Note that the level of recovered C214 is reduced in 
lane 4 compared to lane 2. The input lanes account for 20% of the amounts used in all the reactions for C214 and the reactions 
shown in lane 2 and 3 for SmB'. (C) Coilin competes with SMN for Tim50 binding sites. A competition experiment is shown 
wherein individual reactions were set-up containing a fixed amount of GST-Tim50aSac and SMN with increasing amounts of 
coilin fragment (C214). In lane 7, 27 times more coilin fragment was used in the reaction compared to the level of SMN. After 
SDS-PAGE and Western transfer, SMN and the coilin fragment were detected using antibodies specific to each protein. Lanes 
2 and 3 show the binding of the coilin fragment or SMN to GST-Tim50aSac in the absence of competitor, respectively. The coi-
lin fragment was added to the reactions containing GST-Tim5aSac and SMN starting at lane 4. As can been seen in lane 7, as 
more coilin fragment binds to GST-Tim50aSac, very little SMN is recovered. The input lane accounts for 20% of the amounts 
used in all the reactions for SMN and the reactions shown in lane 2 and 4 for the coilin fragment.
Input
SMN
1X 3X 9X 27X
Lane 1 2 3 4 5 6
SmB’
SmB’
GST-Tim50aSac A
Lane 1 2 3 4
1X 3X Input
C214
GST-Tim50aSac
SmB’
SmB’
B
Input
GST-Tim50aSac
C214
1 Lane 2 3 4 5 6 7
SMN
Coilin
(C214)
C
1X 3X 9X 27XBMC Cell Biology 2005, 6:29 http://www.biomedcentral.com/1471-2121/6/29
Page 11 of 14
(page number not for citation purposes)
Conclusion
The cellular localization and protein interaction charac-
teristics of Tim50a suggest that this isoform of Tim50 may
play a role in snRNP biogenesis. Based on the abundance
of ESTs, it is likely that Tim50, not Tim50a, is the major
product of the TIMM50 gene. However, the presence of
Tim50a ESTs from cancer cell lines suggests that this
protein may be induced in cellular transformation. It is
known that cancer cells contain CBs, while some normal
cells and tissues do not [41,35]. For example, normal
adult lung tissue does not contain CBs, but lung cancer
cells do. Since CBs play a role in snRNP biogenesis, it is
likely that the increase of CBs in transformed cells reflects
on the heightened demand in splicing requirements for
upregulated genes that participate in the establishment
and/or maintenance of the altered cellular physiology
Tim50a interacts with SMN and snRNPs in vivo Figure 8
Tim50a interacts with SMN and snRNPs in vivo. (A) SMN and Tim50a form a complex in vivo. HeLa cells were trans-
fected with empty GFP vector or GFP-tagged Tim50a and Tim50aN87. Lysate was subjected to immunoprecipitation with pol-
yclonal anti-GFP antibodies, followed by Western blotting and probing with anti-SMN antibodies (top panel). The blot was 
reprobed with monoclonal anti-GFP (lower panel) to visualize the level of immunoprecipitated GFP, GFP-Tim50a and GFP-
Tim50aN87. (B) Tim50a and Tim50 form a complex with snRNPs. HeLa cells were transfected with empty GFP vector, GFP-
tagged Tim50a or GFP-Tim50 and lysate was subjected to immunoprecipitation with anti-Sm (Y12) antibodies, followed by 
Western blotting and probing with anti-GFP antibodies. Immunoglobulin heavy IgG(H) chains are marked. The input lanes rep-
resent 2% of the amount of lysate used in the immunoprecipitation reactions and have been overexposed five-fold relative to 
the immunoprecipitation reactions in order to visualize the GFP-Tim50a signal. (C) Tim50a and Tim50 bind the Sm protein, 
SmB'. HeLa cells were transfected with myc-tagged Tim50a or Tim50 and lysate was incubated with beads loaded with GST or 
GST-SmB', followed by Western blotting and probing with anti-myc antibodies. The input lanes represent 2% of the amount of 
lysate used in the pulldown reactions. Approximately equal amounts of GST and GST-SmB' proteins were used.
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[42]. The induction of CBs may also facilitate the produc-
tion of telomerase, the RNA component of which local-
izes to CBs [43,44]. In addition to cancer cells neuronal
cells contain robust CBs [45], possibly because high levels
of snRNPs are necessary to process the abundance of mes-
sages subject to alternative splicing in neuronal tissue
[46]. Therefore, Tim50a expression may be limited to tis-
sue with high demands in snRNP metabolism. We are cur-
rently developing an antibody to the unique N-terminus
of Tim50a in order to explore this possibility.
Additionally, experiments are underway to verify the role
of Tim50a in snRNP biogenesis. In particular, we are inter-
esting in determining if Tim50a is involved in the libera-
tion of snRNPs from the CB after they have been
modified. The functional consequence of the interaction
between Tim50a and SMN is also being investigated.
Finally we note that Tim50a contains the phosphatase
domain shown to be functional in the Tim50 isoform
[36], and thus may alter CB activity by modifying coilin, a
known phosphoprotein [45].
Methods
Yeast two-hybrid screen, plasmid construction and 
mutagenesis
A human brain cDNA library cloned into the prey vector
pACT2 and pretransformed into the yeast strain Y187 (BD
Biosciences, Palo Alto, CA) was mated with the strain
PJ69-2A harboring the bait vector pAS2-l-coilin(362–576,
C214) per the manufacturer's instructions. After mating,
the yeast were plated onto medium lacking tryptophan,
leucine, histidine and adenine (to select for bait, prey and
protein interaction). Colonies were picked after several
days of incubation and the prey plasmid was isolated and
transformed into PJ69-2A containing pAS2-1-C214 or
control bait plasmids to confirm the specificity of the
interaction. Restriction digests and sequencing revealed
that nine different prey cDNAs were recovered, one of
which was termed CAP50. CAP50 was sequenced and the
results were used to conduct a BLAST search on the NCBI
website. Based on this analysis, we concluded that CAP50
contained the partial coding sequence for the protein
Tim50 [36]. Several expressed sequence tags (ESTs) corre-
sponding to Tim50 are present in the database. One EST,
BE386959, contains upstream sequence information not
found in the majority of Tim50 ESTs or reflected in the
Tim50 protein sequence. We procured EST BE386959 and
used this cDNA as a template in a PCR reaction with prim-
ers designed to amplify the Tim50a isoform (BamHI For-
ward primer:
5'GTCGGGATCCATGGCCTCAGCTTTATCTCT-3' and
EcoRl reverse primer: 5'-TCGGAATTCGAGGCCCAGAGT-
TCAGGGCT-3'). The TIM50a amplified product was
cloned in frame into the pEGFP-Cl vector (BD Bio-
sciences, Palo Alto, CA) at EcoRI + BglII restriction enzyme
sites. Tim50a was also cloned in frame into pGEX-2T
(Amersham Pharmacia, Uppsala, Sweden) and pET28a
(Novagen, Madison, WI) vectors at EcoRI + BamHI sites
and utilized for bacterial protein expression. Various
mutants of TIM50a were produced from specific restric-
tion enzyme sites that were located within the TIM50a
coding sequence or in pEGFP-C1. These constructs
included TIM50aN87 (SmaI deletion), TIM50aSac (SacI
internal deletion) and TIM50aN135 (ApaI deletion). Also,
CAP50 obtained from the yeast two-hybrid screen was
digested with BamHI + BglII. and cloned in frame into
pGEX-2T at a BamHI site and utilized for bacterial protein
expression, or digested with BamHI + EcoRI and cloned in
frame into pEGFP-Cl at the equivalent sites for transient
transfection experiments. The mitochondrial Tim50 was
cloned into various expression vectors by standard
techniques.
PCR and nested PCR of Tim50 isoforms on cancer cell line 
cDNA
PCR reactions were performed in the DNA Engine PTC-
200 Peltier Thermal Cycler (MJ Research, Watertown,
MA). The cDNA from four cancer cell lines were kindly
provided by Dr. Laree Hiser (The University of Missis-
sippi, Medical Center): NIH: OVCAR-3 (ovarian cancer),
HCT-15 (colon cancer), A-549 (non-small cell lung can-
cer) and MDA-MB-231 (breast cancer). These cDNA were
shown by Dr. Hiser to be free of genomic DNA. Two sets
of primers were used in the PCR reactions, the sequence of
which can be provided upon request. The first set
(ComFor+ComRev) was designed to amplify a region
common to both Tim50a and Tim50, thus providing a
method to monitor the total expression level of the
TIMM50 gene. The second set of primers (50aFor+50aRev
or 50anRev) bind specifically to Tim50a and not Tim50,
thereby allowing the level of the Tim50a transcript to be
assessed. A standard reaction, consisting of 30 cycles of
amplification and the ComFor + ComRev primers, was
used to amplify the common region of Tim50/Tim50a
from cDNA. Plasmid containing the Tim50a cDNA (10
ng) and water served as positive and negative controls,
respectively. To observe the Tim50a isoform, nested PCR
had to be conducted. For these reactions, 30 cycles of
amplification using the 50aFor+50aRev primers was con-
ducted using the cDNA as template in a 25 µl reaction.
Water and 10 ng of Tim50a plasmid served as negative
and positive controls, respectively. 0.1 µl of each product,
including the negative and positive controls, was then
used as a template in a 25 µl reaction with a second pair
of primers (50aFor+50anRev) for 20 cycles of amplifica-
tion. The resultant products were cloned and sequenced to
verify that they were derived from the Tim50a isoform.
Nested PCR using NIH:OVCAR-3 cDNA consistently
yielded two products. Sequencing demonstrated that the
upper product was from Tim50a while the lower productBMC Cell Biology 2005, 6:29 http://www.biomedcentral.com/1471-2121/6/29
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was from an unrelated message with partial homology to
the primers used in the nested PCR reaction.
Cell Culture, Transfection, Immunofluorescence, and 
Immunoprecipitation
HeLa cells from the American Type Culture Collection
(ATCC) were cultured, transfected with Superfect (Qia-
gen, Valencia, CA) and processed as described [28,29,47].
Where indicated, actinomycin D was used at 5 µg/ml for
two hours. For immunofluorescence, cells were grown on
chamberslides and fixed with 4% paraformaldehyde
followed by the permeabilization with 0.5% Triton X-100.
The permeable cells were then blocked with 10% normal
goat serum for 30 min and probed with the corresponding
primary and secondary antibodies. For immunoprecipita-
tion, whole cell lysate was obtained from HeLa cells trans-
fected with specific constructs. Cells were lysed in 50 mM
Tris, pH 7.5, 150 mM NaCl, 1% NP-40,1% sodium deox-
ycholate, 0.1% SDS, 2 mM EDTA plus 1 tablet of complete
protease inhibitor cocktail (Roche, Mannheim, Germany)
per 50 ml lysis solution. The lysates were then repeatedly
passed through a 25-gauge needle to shear DNA. The cell
lysate was incubated at 4°C for one hour with primary
antibody, followed by the addition of Sepharose beads
(Amersham Pharmacia, Uppsala, Sweden) and an addi-
tional one hour of incubation. Both incubation periods
were accompanied with gentle rotation. The beads were
washed with 1 ml lysis solution 5 times, resuspended in
5X SDS loading buffer, boiled, and subject to SDS-PAGE
and Western blotting as described [47]. Antibodies used
for this experimentation include anti-SMN (BD Bio-
sciences, Palo Alto, CA, catalog number 610646), anti-
GFP (polyclonal, BD Biosciences, Palo Alto, CA, catalog
number 632459; monoclonal, Roche, Indianapolis, IN,
catalog number 1814460) and anti-Sm (Y12) (Lab Vision,
Freemont, CA, catalog number MS-450-P).
In vitro binding assays
GST-tagged and His-tagged constructs, after transforma-
tion into E. coil BL21(DE3)pLysS cells, were induced and
purified as described [28]. In binding reactions, approxi-
mately 1 µg of His-T7-tagged protein was incubated with
1 µg of the GST-fusion protein in 1 ml of lysis buffer plus
2 mM DTT. After incubation for 1 hour at 4°C with gentle
inversion, the beads were washed 5 times (1 ml each) with
lysis buffer plus DTT, resuspended in 10 µl 5X SDS
loading buffer, boiled and subjected to SDS-PAGE. Pri-
mary antibodies used included anti-T7 (Novagen, Madi-
son, WI, 1:1000), anti-SMN (described above) and anti-
coilin [48], 1:500). Competition experiments were per-
formed as described [28], except that increasing amounts
of SmB' or coilin fragment were used.
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